Table 3.
Group | Vaccination | Challenge | |||
---|---|---|---|---|---|
Vaccine administered | Vaccine virus titer in nasal washes, day 3 (log10EID50/ml) | WT challenge virus given, day 21 | WT challenge virus titer in nasal washes, day 24 (log10EID50/ml) | WT challenge virus titer in lung tissue, day 24 (log10EID50/ml per g) | |
1 | B/Vic LAIV | 3.88 ± 0.119 | B/Vic WT virus | 0.90 ± 0.900 | < 1.5 |
2 | B/Vic LAIV | B/Yam WT virus | 1.67 ± 0.953 | < 1.5 | |
3 | B/Yam LAIV | 3.68 ± 0.120 | B/Yam WT virus | 0.70 ± 0.700 | < 1.5 |
4 | B/Yam LAIV | B/Vic WT virus | 1.83 ± 0.970 | < 1.5 | |
5 | None | n.d.1 | B/Vic WT virus | 5.53 ± 0.167 | 3.01 ± 0.200 |
6 | None | n.d. | B/Yam WT virus | 3.70 ± 0.764 | 0.96 ± 0.957 |
7 | None | < 1.52 | None | < 1.5 | < 1.5 |
1n.d.: not determined. 2Estimated threshold limit value.